Nuclera

Nuclera’s mission is to better human health by enabling scientists to easily access the proteins
they need for drug discovery research. The Company’s eProtein Discovery™ benchtop system
accelerates protein expression and purification workflows within labs.

The platform reduces the timelines and costs associated with protein expression and
purification through automated construct screening to inform protein scale-up resulting in mg
amounts in less than 48 hours. Integrating digital microfluidics, protein quality assays, and cell-
free protein synthesis on smart cartridges, eProtein Discovery enables rapid access to even
challenging proteins at high quality.

Founded in 2013, Nuclera’s offices are located in Cambridge (UK) and Boston (US).

For more information please visit: www.nuclera.com